Skip to main content
OpenTrials
Completed

NCT Number: NCT05498883

Quality of Life Evaluation with the SRI Questionnaire of ALS Patient with Non-invasive Ventilation

This study aims to measure the quality of life of ALS patients by the SRI questionnaire, in two distinct patient groups : Patient requiring initiation of NIV, and patients 24 hours dependent on NIV

This study also seeks to assess the quality of life of the caregivers with the Zarit Burden interview in those two populations

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pneumology departement, Pitié-Salpêtrière hospital, GHU APHP-Sorbonne Université

Paris, 75013, France

About this study

The course of the study is as follows:

Patient newly ventilated with NIV :

inclusion is done on the day of starting NIV. On the day of inclusion: Clinical examination, completion of the ALS-FRS score, completion of the SRI score.

For the caregiver: Completion of the Zarit Burden Inerview Reassessment of scores (SRI, Zarit-burden, ALS-FRS), at three-month and six-month follow-up

Patient dependent of NIV :

On the day of inclusion: Clinical examination, completion of the ALS-FRS score, completion of the SRI score.

For the caregiver: Completion of the Zarit Burden Inerview Reassessment of scores (SRI, Zarit-burden, ALS-FRS), at three-month follow-up

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients :

  • 18 years or more
  • Patient followed for ALS probable or certain with Awaji criteria
  • group 1 : severe chronic respiratory failure, with a decision by the attending physician to start NIV
  • group 2 : complete dependence on NIV

Caregivers :

  • 18 years or more
  • Informed and does not object to the study
  • Primary caregiver for more than 3 months of an ALS patient on NIV (either at initiation or with 24 hours NIV dependence)
  • More than 30 hours spent at home per week
  • Met the inclusion criteria for group 1 (NIV initiation) or group 2 (24 hours NIV dependence)

Exclusion criteria

Patients :

  • Patient under legal protection/ guardianship
  • insufficient command of French
  • Severe cognitive impairment, particularly in relation to frontotemporal degeneration
  • No indication criteria for NIV.

Caregivers :

  • insufficient command of French
  • Caregiver of a patient with another chronic pathology

Treatment and study plan

Score completion

Other

completion of the SRI score

Primary outcomes

  1. SRI questionnaire in patients who have indication for starting NIV

    Time frame: six months

    SRI questionnaire assessment at initiation of NIV, at 3-month follow-up and at 6-month follow-up

Secondary outcomes

  1. SRI of patients with total ventilatory dependence in ALS

    Time frame: three months

    SRI questionnaire assessment at inclusion and at 3-month follow-up

  2. Zarit burden interview in both groups

    Time frame: Six months

    Zarit Burden interview questionnaire in ALS patient caregiver, in both groups (initiation of NIV and NIV-dependent patients) at inclusion, 3-month follow-up (both groups) and at 6-month follow-up (in group 1)

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Acronym: Quality EvALS

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Aug 12, 2022
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.